This report expands the mutational spectrum of LQT2 and exemplifies the utility of genomic sequencing in elucidating arrhythmia-associated genetic defects to enable early diagnosis and personalized management of cardiac channelopathies. The gene discussed is KCNH2; the disease is cardiac arrhythmia.